Belvedere Trading’s Gossamer Bio GOSS Stock Holding History

Belvedere Trading’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-33	Closed	-$31K	–	1162
2022 Q3	$31K	Buy	33 +15	+83%	+$14.9K	﹤0.01%	230
2022 Q2	$17K	Buy	+18	New	+$11.2K	﹤0.01%	323

Other funds holding GOSS

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Belvedere Trading's GOSS Position: Q4 2022 in Review

Belvedere Trading sold out of Gossamer Bio (GOSS) in Q4 2022, closing a stake of 544 shares — an estimated $523K sold.

Belvedere Trading first reported a position in GOSS in Q4 2021 and held it in 3 quarters. The position peaked at $523K in Q3 2022. 118 funds tracked by Wall St. Rank hold GOSS as of Q4 2022.

Belvedere Trading reported no remaining Gossamer Bio position as of Q4 2022 after selling out during the quarter.
Belvedere Trading sold 544 Gossamer Bio shares in Q4 2022, an estimated $523K.
Belvedere Trading first reported a position in Gossamer Bio in Q4 2021 and held it in 3 quarters.
Belvedere Trading's Gossamer Bio position peaked at $523K in Q3 2022.
118 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2022.

Based on Belvedere Trading's 13F filing for Q4 2022, filed 15 Feb 2023.